Successful laser treatment of vandetanib-associated cutaneous pigmentation

Archives of Dermatology

Volumn 147, Issue 3, 2011, Pages 364-365

  Brooks, Sara ^a   Linehan, W Marston ^b   Srinivasan, Ramaprasad ^b   Kong, Heidi H ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; VANDETANIB;

ACNE; ADULT; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; KIDNEY CARCINOMA; LETTER; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; VON HIPPEL LINDAU DISEASE;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPIGMENTATION; LASERS, SOLID-STATE; PIPERIDINES; PROTEIN KINASE INHIBITORS; QUINAZOLINES; SKIN PIGMENTATION;

EID: 79952821869     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.30     Document Type: Letter

References (4)

1. Kong HH, Fine HA, Stern JB, Turner ML. Cutaneous pigmentation after photosensitivity induced by vandetanib therapy. Arch Dermatol. 2009;145(8):923-925.
2. Green D, Friedman KJ. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol. 2001;44(2)(suppl):342-347. (Pubitemid 32167662)
3. Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg. 2004;30(9):1201-1204. (Pubitemid 39312240)
4. Tsao H, Busam K, Barnhill RL, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol. 1996;132(10):1250-1251.